Preclinical pharmacokinetic modeling and clinical translation of SIG001, a novel anti-cancer therapeutic antibody targeting on cancer-derived sialylated IgG.

SIG-001 - Eli Lilly

SIG001 - Guangzhou SIG Biomedical Technology

http://www.ncbi.nlm.nih.gov/pubmed/42745873

Chen Liu; Qingyu Yao; Shenghua Zhang; Xiaoyan Qiu; Yaou Liu; Ying Zhou

Sep 17, 2026